Skip to main content

Table 2 Baseline clinical characteristics of patients with stable or progressive disease

From: Variability of forced vital capacity in progressive interstitial lung disease: a prospective observational study

 

All

(n = 40)

stable

(n = 28)

progressive

(n = 12)

p-value

Age (years)

60.7 ± 11.3

59.6 ± 12.6

63.1 ± 7.6

0.59

FVC, % predicted

64.7 ± 21.7

67.1 ± 21.9

59.2 ± 21.1

0.31

DLCO, % predicteda

41.2 ± 19.7

43.1 ± 21.3

36.3 ± 18.4

0.33

6MWD (m)b

390 ± 123

433 ± 89

301 ± 140

0.009

SGRQc

52.8 ± 18.9

55.2 ± 19.4

48.0 ± 17.7

0.18

K-BILD

52.9 ± 12.2

55.8 ± 12.7

46.3 ± 8.1

0.004

VAS cough

3.3 ± 2.6

2.8 ± 2.5

4.4 ± 2.5

0.06

  1. Data are presented as mean ± standard deviation. Definition of abbreviations: 6MWD 6-min walk distance, DLCO diffusion capacity for carbon monoxide, FVC forced vital capacity, K-BILD King’s Brief Interstitial Lung Disease, SGRQ St George’s Respiratory Questionnaire, VAS visual analog scale
  2. a n = 26 patients (stable: n = 19; progressive: n = 7); b n = 34 patients (stable: n = 23; progressive: n = 11); c n = 37 patients (stable: n = 25; progressive: n = 12);
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us